)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
C-MER Medical
C-MER Medical (3309) investor relations material
C-MER Medical H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary25 Aug, 2026
Executive summary
Revenue grew 8.5% year-over-year to HK$1,024.4 million for the six months ended 30 June 2026, driven by growth in Mainland China dental and ophthalmic businesses.
Profit attributable to equity holders rose 0.2% to HK$50.0 million, while adjusted profit (excluding Mainland China other business losses) declined 5.2% to HK$66.0 million.
Gross profit increased 10.0% to HK$323.4 million, with gross margin improving to 31.6%.
Net cash from operating activities more than doubled to HK$218.6 million.
Financial highlights
Revenue from Mainland China rose 16.3% to HK$554.9 million, while Hong Kong revenue was stable at HK$469.6 million.
Dental services revenue surged 19.0% to HK$282.5 million, mainly due to Shenzhen CKJ's brand strength.
Ophthalmic services revenue grew 3.0% to HK$631.5 million, with Mainland China demand offsetting a slight decline in Hong Kong.
Net profit margin was 5.6%, down from 5.9% a year earlier.
Basic and diluted EPS were HK4.21 cents.
Outlook and guidance
Demand for ophthalmic services in Hong Kong remains strong due to an aging population.
Mainland China ophthalmic business continues to improve but faces intense competition.
Cross-border medical consumption is expected to benefit dental and hospital operations in Shenzhen.
Strategic focus on expanding ophthalmic and dental services, operational efficiency, and innovation investments.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from C-MER Medical
- Profit rebounded to HK$100.4 million as adjusted profit and margins improved significantly.3309
H2 2025 - Profit surged 62.4% to HK$49.9M on strong Hong Kong demand and cost controls.3309H1 2025
- Net profit rebounded on 11.1% revenue growth, led by Mainland China dental and medical services.3309H2 2023
- Net profit rose 28% to HK$48.6M as Mainland China dental growth offset lower revenue.3309H1 2024
- Impairments drove a net loss despite robust dental growth and stable core revenue.3309H2 2024
Next C-MER Medical earnings date
H2 202626 Mar, 2027
C-MER Medical
Next C-MER Medical earnings date
H2 202626 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
C-MER Medical Holdings Limited is a healthcare company specializing in the provision of ophthalmic services, including eye surgeries, vision correction, and general eye care. The company operates a network of eye clinics and surgical centers primarily in Hong Kong and mainland China, offering treatments for conditions such as cataracts, myopia, glaucoma, and retinal diseases. C-MER Medical is committed to delivering high-quality medical services by employing advanced ophthalmic technology and experienced medical professionals. C-MER Medical Holdings Limited is headquartered in Hong Kong, China, and its shares are listed on the Hong Kong Stock Exchange.